Raniah I. Alnaser, M.Sc., is a pharmacist, academic, and researcher involved in pharmacy education, academic activities, and pharmaceutical research, with interests in pharmacology, diabetes mellitus, metabolic disorders, and the therapeutic potential of medicines in disease prevention and management.
Her research contributions include studies and review articles addressing antidiabetic agents, diabetes-related complications, oxidative stress, insulin resistance, and the potential therapeutic role of melatonin and incretin-based therapies. Her publications also explore the relationship between pharmacological interventions and clinical outcomes, reflecting her interest in evidence-based medicine and improving patient care.
Through her academic and research activities, Raniah I. Alnaser contributes to the advancement of pharmaceutical sciences and the development of clinically relevant research. Her work reflects an interest in integrating pharmacological knowledge, scientific evidence, and pharmacy practice to support better healthcare outcomes.